tiprankstipranks
DMK Pharmaceuticals (DMKPQ)
OTHER OTC:DMKPQ
US Market

DMK Pharmaceuticals (DMKPQ) Financial Statements

Compare
1,113 Followers

DMK Pharmaceuticals Financial Overview

DMK Pharmaceuticals's market cap is currently $10.00. The company's EPS TTM is $-9.18; its P/E ratio is ―; DMK Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 4.76M$ 2.21M$ 2.78M$ 22.11M$ 15.09M
Gross Profit$ -2.90M$ -4.66M$ -3.55M$ 6.44M$ 2.19M
Operating Income$ -25.06M$ -32.07M$ -31.68M$ -30.00M$ -40.35M
EBITDA$ -23.58M$ -30.63M$ -33.51M$ -25.07M$ -37.02M
Net Income$ -26.48M$ -45.83M$ -49.39M$ -27.51M$ -39.01M
Balance Sheet
Cash & Short-Term Investments$ 1.11M$ 23.25M$ 6.75M$ 8.81M$ 19.27M
Total Assets$ 10.93M$ 38.30M$ 30.87M$ 47.84M$ 58.36M
Total Debt$ 342.56K$ 692.43K$ 4.21M$ 4.08M$ 2.58M
Net Debt$ -738.80K$ -22.56M$ -2.54M$ -4.73M$ -16.69M
Total Liabilities$ 11.58M$ 12.42M$ 27.37M$ 14.84M$ 11.67M
Stockholders' Equity$ -650.76K$ 25.88M$ 3.50M$ 33.00M$ 46.69M
Cash Flow
Free Cash Flow$ -26.58M$ -39.01M$ -21.60M$ -22.75M$ -36.19M
Operating Cash Flow$ -25.90M$ -37.79M$ -20.90M$ -19.89M$ -32.66M
Investing Cash Flow$ 3.48M$ 282.74K$ -946.21K$ -2.87M$ -3.54M
Financing Cash Flow$ 285.00K$ 53.94M$ 19.89M$ 12.29M$ 37.13M
Currency in USD

DMK Pharmaceuticals Earnings and Revenue History

DMK Pharmaceuticals Debt to Assets

DMK Pharmaceuticals Cash Flow

DMK Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis